Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Lian, Wei S ^b,c   Lin, Heng ^d   Cheng, Winston Tk ^e   Kikuchi, Tateki ^b   Cheng, Ching F ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; IRON; SIMVASTATIN; TIROFIBAN; DRUG DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE; HISTOPATHOLOGY; INFLAMMATION; INTRACARDIAC THROMBOSIS; LEUKOCYTOSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOGENESIS; THROMBUS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; ENDOTHELIUM CELL; FIBROSIS; HEART VENTRICLE; MYOCARDITIS; PATHOLOGY; PHYSIOLOGY; THROMBOSIS;

MUS;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FIBROSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART VENTRICLES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IRON; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MYOCARDITIS; SIMVASTATIN; THROMBOSIS; TYROSINE;

EID: 79955100019     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-26     Document Type: Article

References (40)

1. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. I Petit M Szyper-Kravitz A Nagler M Lahav A Peled L Habler T Ponomaryov RS Taichman F Arenzana-Seisdedos N Fujii J Sandbank D Zipori T Lapidot, Nat Immunol 2002 3 687 694 10.1038/ni813 12068293 (Pubitemid 34752479)
2. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. JP Lévesque J Hendy Y Takamatsu PJ Simmons LJ Bendall, J Clin Invest 2003 111 187 196 12531874 (Pubitemid 36105917)
3. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. M Harada Y Qin H Takano T Minamino Y Zou H Toko M Ohtsuka K Matsuura M Sano J Nishi K Iwanaga H Akazawa T Kunieda W Zhu H Hasegawa K Kunisada T Nagai H Nakaya K Yamauchi-Takihara I Komuro, Nat Med 2005 11 305 311 10.1038/nm1199 15723072 (Pubitemid 40460559)
4. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. S Minatoguchi G Takemura XH Chen N Wang Y Uno M Koda M Arai Y Misao C Lu K Suzuki K Goto A Komada T Takahashi K Kosai T Fujiwara H Fujiwara, Circulation 2004 109 2572 2580 10.1161/01.CIR.0000129770.93985.3E 15123535 (Pubitemid 38720559)
5. Differential Effect of Intracoronary Infusion of Mobilized Peripheral Blood Stem Cells by Granulocyte Colony-Stimulating Factor on Left Ventricular Function and Remodeling in Patients With Acute Myocardial Infarction Versus Old Myocardial Infarction: The MAGIC Cell-3-DES Randomized, Controlled Trial. HJ Kang HY Lee SH Na SA Chang KW Park HK Kim SY Kim HJ Chang W Lee WJ Kang BK Koo YJ Kim DS Lee DW Sohn KS Han BH Oh YB Park HS Kim, Circulation 2006 114 1 Suppl 145 I151 16820564
6. Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis. H Ince M Valgimigli M Petzsch JS de Lezo F Kuethe S Dunkelmann G Biondi-Zoccai CA Nienaber, Heart 2008 94 610 616 10.1136/hrt.2006.111385 17761504 (Pubitemid 351580136)
7. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. A Abdel-Latif R Bolli EK Zuba-Surma IM Tleyjeh CA Hornung B Dawn, Am Heart J 2008 156 216 226 10.1016/j.ahj.2008.03.024 18657649
8. Stem cell mobilization by granulocyte colony- stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. D Zohlnhöfer A Dibra T Koppara A de Waha RS Ripa J Kastrup M Valgimigli A Schömig A Kastrati, J Am Coll Cardiol 2008 51 1429 1437 18402895 (Pubitemid 351470028)
9. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. HJ Kang HS Kim SY Zhang KW Park HJ Cho BK Koo YJ Kim LD Soo DW Sohn KS Han BH Oh MM Lee YB Park, Lancet 2004 363 751 756 10.1016/S0140-6736(04)15689-4 15016484
10. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. JM Hill MA Syed AE Arai TM Powell JD Paul G Zalos EJ Read HM Khuu SF Leitman M Horne G Csako CE Dunbar MA Waclawiw RO Cannon, J Am Coll Cardiol 2005 46 1643 1648 10.1016/j.jacc.2005.01.067 16256862 (Pubitemid 41531616)
11. Late stent thrombosis after transcoronary transplantation of granulocyte-colony stimulating factor-mobilized peripheral blood stem cells following primary percutaneous intervention for acute myocardial infarction. C Steinwender R Hofmann A Kypta C Gabriel F Leisch, Int J Cardiol 2007 122 248 249 10.1016/j.ijcard.2006.11.074 17275936 (Pubitemid 47615177)
12. Induction of a hypercoagulability state and endothelial cell activation by G-CSF in peripheral blood stem cell donors. MA Canales R Arrieta R Gomez-Rioja J Diez V Jimenez-Yuste F Hernandez-Navarro, J Hematother Stem Cell Res 2002 11 675 681 10.1089/15258160260194820 12201956 (Pubitemid 34851799)
13. G-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell aphaeresis donors. C Karadogan I Karadogan AU Bilgin L Undar, Ther Apher Dia 2006 10 180 186 10.1111/j.1744-9987.2006.00361.x
14. Administration of granulocyte-colony- stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. P Topcuoglu M Arat K Dalva M Ozcan, Bone Marrow Transplant 2004 33 171 176 10.1038/sj.bmt.1704341 14647251 (Pubitemid 38180929)
15. Rat models of arterial thrombosis induced by ferric chloride. KD Kurz BW Main GE Sandusky, Thromb Res 1990 60 269 280 10.1016/0049-3848(90)90106-M 2087688
16. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. SM Day D Duquaine LV Mundada RG Menon BV Khan S Rajagopalan WP Fay, Circulation 2003 107 2601 2606 12732602 (Pubitemid 36628943)
17. Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis. G Russo JA Leopold J Loscalzo, Vasc Pharmacol 2002 38 259 269 10.1016/S1537-1891(02)00250-1 (Pubitemid 36398259)
18. Beneficial cardiovascular pleiotropic effects of statins. J Davignon, Circulation 2004 109 23 Suppl 1 II39 III43 15198965
19. Pleiotropic effects of statins. JK Liao U Laufs, Annu Rev Pharmacol Toxicol 2005 45 89 118 10.1146/annurev.pharmtox.45.120403.095748 15822172 (Pubitemid 40261799)
20. 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. GY Oudit H Sun MG Trivieri SE Koch F Dawood C Ackerley M Yazdanpanah GJ Wilson A Schwartz PP Liu PH Backx, Nat Med 2003 9 1187 1194 10.1038/nm920 12937413 (Pubitemid 37173704)
21. Iron overload augments the development of atherosclerotic lesions in rabbits. JA Araujo EL Romano BE Brito V Parthé M Romano M Bracho RF Montão J Cardier, Art Thromb Vasc Biol 1995 15 1172 1180
22. Iron supplementation generates hydroxyl radical in vivo: an ESR spin-trapping investigation. MB Kadiiska MJ Burkitt QH Xiang RP Mason, J Clin Invest 1995 96 1653 1657 10.1172/JCI118205 7657835
23. Pathophysiology of Iron Overload. C Hershko G Link I Cabantchik, Ann NY Acad Sci 1998 850 191 201 10.1111/j.1749-6632.1998.tb10475.x 9668540 (Pubitemid 28369759)
24. Molecular analysis of the granulocyte colony-stimulating factor receptor. BR Avalos, Blood 1996 88 761 777 8704229 (Pubitemid 26333294)
25. Tissue factor up-regulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications. AJ Chu, Cell Biochem Funct 2006 24 173 192 10.1002/cbf.1200 15617024
26. Role of tissue factor in hemostasis and thrombosis. N Mackman, Blood Cells Mol Dis 2006 36 104 107 10.1016/j.bcmd.2005.12.008 16466951
27. Platelets in inflammation and atherogenesis. M Gawaz H Langer AE May, J Clin Invest 2005 115 3378 3384 10.1172/JCI27196 16322783 (Pubitemid 43121822)
28. Platelet-leukocyte interactions in inflammation and atherothrombosis. AE May H Langer P Seizer B Bigalke S Lindemann M Gawaz, Semin Thromb Hemost 2007 33 123 127 10.1055/s-2007-969023 17340459 (Pubitemid 46427753)
29. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. L Wang EE Johnson HN Shi WA Walker M Wessling-Resnick BJ Cherayil, J Immunology 2008 181 2723 2731
30. Iron primes hepatic macrophages for NF-kappaB activation in alcoholic liver injury. H Tsukamoto M Lin M Ohata C Giulivi SW French G Brittenham, Am J Physiol 1999 277 1240 1250 10600822
31. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. M Ohtsuka H Takano Y Zou H Toko H Akazawa Y Qin M Suzuki H Hasegawa H Nakaya I Komuro, FASEB J 2004 18 851 853 15001565
32. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. E Deindl MM Zaruba S Brunner B Huber U Mehl G Assmann IE Hoefer J Mueller-Hoecker WM Franz, FASEB J 2006 20 27 E36 10.1096/fj.05-4763fje (Pubitemid 44961988)
33. Granulocyte colony-stimulating factor improves left ventricular function of doxorubicin- induced cardiomyopathy. L Li G Takemura Y Li S Miyata M Esaki H Okada H Kanamori A Ogino R Maruyama M Nakagawa S Minatoguchi T Fujiwara H Fujiwara, Lab Invest 2007 87 440 455 10.1038/labinvest.3700516 17334414 (Pubitemid 46633120)
34. Anti-inflammatory effects of granulocyte colony-stimulating factor. T Hartung, Curr Opin Hematol 1998 5 221 225 10.1097/00062752-199805000-00013 9664164 (Pubitemid 28360550)
35. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction. H Takano Y Qin H Hasegawa K Ueda Y Niitsuma M Ohtsuka I Komuro, J Mol Med 2006 84 185 193 10.1007/s00109-005-0035-z 16418824 (Pubitemid 43291007)
36. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? BS Coller, Aterioscler Thromb Vasc Biol 2005 25 658 670 10.1161/01.ATV.0000156877.94472.a5 (Pubitemid 40463851)
37. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Y Kureishi Z Luo I Shiojima A Bialik D Fulton DJ Lefer WC Sessa K Walsh, Nat Med 2000 6 1004 1010 10.1038/79510 10973320
38. Beyond lipid-lowering: effects of statins on endothelial nitric oxide. U Laufs, Eur J Clin Pharmacol 2003 58 719 731 12634978 (Pubitemid 36399228)
39. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. D Fulton JP Gratton TJ McCabe J Fontana Y Fujio K Walsh TF Franke A Papapetropoulos WC Sessa, Nature 1999 399 597 601 10.1038/21218 10376602
40. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. S Dimmeler I Fleming B Fisslthaler C Hermann R Busse AM Zeiher, Nature 1999 399 601 605 10.1038/21224 10376603